Skip to content
Dose Brief
Menu
No. 162 here · Grade C

Lttl review

A telehealth provider that publishes every price it charges — every product, every commitment length, before any intake quiz — and then advertises itself with the twelve-month prepay rung of three separate product lines.

Visit Lttl Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$199/mo (month-to-month, all doses, compounded; prepay tiers lower)
Tirzepatide
$279/mo (month-to-month, all doses, compounded; prepay tiers lower)
Coverage
Coverage not published
Brand-name
Compounded only

Prices read from Lttl's own site on . Providers change pricing without notice — check the current figure before you buy.

On the trackerStableprice stable— Second reading. We filed $199/mo semaglutide and $279/mo tirzepatide on 1 August and re-read the /plans matrix on 7 August 2026: both month-to-month rates are unchanged, as are all four commitment rungs behind them. The "$129/mo" the homepage advertises is the twelve-month prepay rate, and it has not moved either.

The scorecard

Lttl scored on our six Brief Score factors. See the methodology.

Price Stability66/100
Supply Reliability71/100
Transparency72/100
Access Breadth56/100
Clinical Oversight76/100
Track Record65/100

Lttl in depth

Every price Lttl advertises on its front page is an annual rate. "Plans start at $129/mo" for weight loss, "$79/mo" for longevity, "$109/mo" for microdosing — each of those is the twelve-month prepay rung of a different product line, not what a new patient pays for a month. Read on August 28, 2026, the homepage carried all three, and the tirzepatide card advertised "Plans start at $199/mo," which is that molecule's twelve-month rung too.

The month-to-month numbers are higher across the board. Reading the plan matrix on August 7, 2026, compounded semaglutide injection ran $199 a month billed monthly, stepping down to $169 on three months, $149 on six and $129 on twelve. Tirzepatide ran $279 monthly, $249, $229, and $199 on the year. The oral semaglutide route started at $229. So the gap between the advertised figure and the month-to-month price is about $70 a month on semaglutide and $80 on tirzepatide.

Committing to the advertised rate means paying the year in one go: $1,548 for semaglutide and $2,388 for tirzepatide, up front. That is a genuine discount for someone who has already decided to stay on the drug for a year, and it is not a monthly subscription anyone can stop after a cycle — which is the distinction the word "/mo" in the headline does the most to blur.

Where Lttl deserves real credit is the plans page itself. Every rung of every ladder is published explicitly, and the monthly option is labeled in the company's own words as billed "every month" — so a reader who opens that page can see exactly what each term costs before choosing. That is more than most of this market discloses, and it is the reason the gap here sits in the advertising rather than in the checkout: the honest number is published, just not on the page most readers land on.

The microdose line at $109 to $149 is a different product, not a cheaper dose of the same one, and it is worth not confusing the two when comparing Lttl against a standard-dose price elsewhere. The site also runs a standing promotion — "Up to $140 off your first month · Code auto-applied" on August 28, 2026 — which reduces the first month only, and cites "Forbes Health's Best Provider of 2026" alongside member-results claims of 32 lbs lost in six months on average.

Treat those outcome figures as marketing rather than trial data: they are the company's own member statistics, with no published methodology behind them, and they sit on the same page as the pricing headlines that describe an annual commitment as a monthly rate.

What we like

  • The full price matrix is public on /plans before any intake quiz — every product, every term rung, and the up-front total each one bills ($1,548 for a year of semaglutide, $2,388 for tirzepatide) — which is more than most providers in this ranking publish anywhere
  • Dose-flat pricing stated in terms: "Same price, every dose", so titrating to a maintenance dose does not raise the monthly bill
  • States plainly that its compounded GLP-1s "are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality" — unusually explicit for the category
  • A microdose line at $149/mo month-to-month for readers who titrate badly at therapeutic doses, and an oral ODT semaglutide route at $229/mo for readers who will not inject
  • Cancel anytime with no contract on the monthly plan, a full refund if a provider finds you medically ineligible, free shipping with cold-chain packaging, and HSA/FSA funds accepted
  • Clean against FDA's warning-letter database under the brand, the domain and the registrant its Terms name, screened 7 August 2026

The caveats

  • Every "Plans start at" figure on the site is a twelve-month prepay rung: $129/mo weight loss is $1,548 up front, $109/mo microdose is $1,308, $79/mo longevity is $948. Month-to-month you pay $199 semaglutide, $279 tirzepatide
  • One advertised price is purchasable at no tier: all fourteen product cards carry the same "$129/mo" starting figure, including tirzepatide — whose own rungs are $279 month-to-month, $249, $229 and $199 prepaid, and never $129 at any term
  • Section 11 of the Terms defines "Partner Pharmacies" and then names four — RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx, with addresses and phone numbers — though the identical block appears on Taurus Meds, Remevi, Embody and Nolu, so it discloses a shared platform bench rather than a Lttl-specific one; separately, the footer's LegitScript link resolves to a generic lookup form with no certification record for the domain
  • No public list of states served; eligibility depends on where unnamed "partner providers are licensed", so a reader cannot check coverage before starting an assessment
  • A persistent site banner promises "Prescribed and shipped within 48 hours" while the shipping policy states 2–5 business days to process plus 3–7 to deliver
  • Medications cannot be returned or refunded once they ship from the pharmacy, and consultation fees are non-refundable once a provider has reviewed your assessment
  • The cheapest figures a first-time visitor sees — "up to $140 off" and the First Month Special — are one-time introductory rates that revert to the standing monthly price at the next refill
  • Does not bill insurance, and the Terms impose mandatory individual arbitration with a class-action waiver

The brief

Best for: Readers who want the whole price matrix in front of them before they answer a single question, and who will check which term a headline figure is attached to before treating it as a monthly bill. A telehealth provider that publishes every price it charges — every product, every commitment length, before any intake quiz — and then advertises itself with the twelve-month prepay rung of three separate product lines.

Ranked #162 of 546 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Before you decide

The questions readers ask next after reading about Lttl.

Closest here

The providers scoring nearest Lttl — the realistic shortlist if you're weighing it.

Weighing Lttl against one provider in particular? There is a full head-to-head with our top-ranked pick in CoreAge Rx vs Lttl, and every provider that outranks it is listed on the Lttl alternatives ranking.

More providers we track (24)

515 more are filed too — see every provider we track, ranked.

Pricing, states and verification reflect Lttl's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Lttl's site. Not medical advice; see our disclosure.

← Back to all rankings